Daniel Yick Chin Heng — Alberta Health Services

Area of research

Pulmonary and Respiratory Medicine · Oncology

Research interest

Research interests include Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Renal and related cancers, and Cancer Genomics and Diagnostics.

Recent publications

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

JAMA Network Open 2024cited by 140position: middledoi

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study

European Urology 2024cited by 24position: middledoi

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Journal of Clinical Oncology 2021cited by 229position: middledoi

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

Journal of Clinical Oncology 2021cited by 165position: middledoi

Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers

The Oncologist 2020cited by 38position: middledoi

Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology 2014cited by 139position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pulmonary and Respiratory Medicine · Oncology →